Aggarwal R, Bhatt DL, Szarek M, Cannon CP, Leiter LA, Inzucchi SE, Lopes RD, McGuire DK, Lewis JB, Riddle MC, Davies MJ, Banks P, Carroll AK, Scirica BM, Ray KK, Kosiborod MN, Cherney DZI, Udell JA, Verma S, Mason RP, Pitt B, Steg PG
Published on December 8, 2023 Read Time: 6 Minutes Three Things to Know Mounjaro (tirzepatide) was FDA-approved in spring 2022 for managing type 2 diabetes
Apparent kinetic rate ( k app ) reflects the rate of observed VitC signal change caused by both T 1 relaxation and VitC production from DHA, while k reflects only the VitC production rate
Quality Certificates Independent third-party lab analysis (CoA) - from our own in-house brand